-
@ English News
2025-04-30 13:06:55Medicenna Presents Promising Preclinical Data from its First-in-Class Tumor Targeted and Conditionally Activated Anti-PD-1-IL-2 Bifunctional Superkine at the Annual 2025 AACR Meeting https://financialpost.com/globe-newswire/medicenna-presents-promising-preclinical-data-from-its-first-in-class-tumor-targeted-and-conditionally-activated-anti-pd-1-il-2-bifunctional-superkine-at-the-annual-2025-aacr-meeting